
Haemonetics grows recurring revenues with plasma consumables and cardiovascular tech, seen as a speculative buy.
Haemonetics, a medtech company, is expanding its recurring revenue through plasma consumables and higher-margin cardiovascular technologies. The company has shifted focus by divesting slower-growth operations and acquiring new businesses like Cardiva...


